featured
Efficacy of Interleukin-17 Inhibitors in Patients With Psoriasis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of the European Academy of Dermatology and Venereology: JEADV
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Blocking Interleukin-17 in Psoriasis: Real-world Experience from the PsoPlus Cohort
J Eur Acad Dermatol Venereol 2022 Dec 23;[EPub Ahead of Print], L Schots, R Soenen, B Blanquart, D Thomas, J LambertFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.